World's Best Scientists 2026 revealed!
Olivia M. Dean

Olivia M. Dean

D-Index & Metrics

Psychology

D-Index
56
Citations
17021
World Ranking
4131
National Ranking
221

Overview

Olivia M. Dean is affiliated with Deakin University in Australia and has predominantly contributed to the fields of Medicine and Neuroscience. Their research output spans various subfields including Psychiatry and Mental Health, Clinical Psychology, Biological Psychiatry, Molecular Biology, and Genetics.

The scientist's research largely focuses on topics related to Bipolar Disorder and Treatment, Tryptophan and Brain Disorders, Schizophrenia Research and Treatment, Child and Adolescent Psychosocial and Emotional Development, Treatment of Major Depression, Mental Health Research Topics, and Stress Responses and Cortisol.

Frequent venues for Olivia M. Dean's publications include the Journal of Affective Disorders, Australian & New Zealand Journal of Psychiatry, Bipolar Disorders, International Journal of Molecular Sciences, and bioRxiv (Cold Spring Harbor Laboratory).

Notable recent papers authored or coauthored by Olivia M. Dean include:

  • Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management, 2023, World Psychiatry
  • Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce, 2022, The World Journal of Biological Psychiatry
  • Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials, 2020, Neuroscience & Biobehavioral Reviews
  • Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin, 2020, BMC Medicine
  • Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: A systematic review and meta analysis, 2021, Neuroscience & Biobehavioral Reviews

Olivia M. Dean has collaborated extensively with a group of frequent coauthors, including Michael Berk, Alyna Turner, Adam J. Walker, Ken Walder, and Sue Cotton.

Best Publications

  • Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

    Michael Berk;Flavio P Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;Olivia Dean;Olivia Dean

  • Oxidative stress in psychiatric disorders : evidence base and therapeutic implications

    Felicity Ng;Michael Berk;Michael Berk;Olivia Dean;Ashley I. Bush

  • A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)

    Felice N Jacka;Adrienne O'Neil;Adrienne O'Neil;Rachelle Opie;Rachelle Opie;Catherine Itsiopoulos

  • The chemistry and biological activities of N-acetylcysteine

    Yuval Samuni;Sara Goldstein;Olivia M. Dean;Olivia M. Dean;Olivia M. Dean;Michael Berk

  • N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

    Michael Berk;David Leon Copolov;David Leon Copolov;Olivia Dean;Olivia Dean;Kristy Lu

  • N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

    Olivia Dean;Frank Giorlando;Michael Berk

  • N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

    Michael Berk;Michael Berk;David Leon Copolov;David Leon Copolov;Olivia Dean;Kristy Lu

  • The promise of N-acetylcysteine in neuropsychiatry.

    Michael Berk;Gin S. Malhi;Gin S. Malhi;Laura J. Gray;Olivia M. Dean;Olivia M. Dean;Olivia M. Dean

  • N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

    Seetal Dodd;Olivia Dean;David Leon Copolov;Gin S Malhi

  • Oxidative & nitrosative stress in depression: why so much stress?

    Steven Moylan;Steven Moylan;Michael Berk;Olivia Dean;Yuval Samuni

  • Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

    Deepmala;Deepmala;John Slattery;Nihit Kumar;Leanna Delhey

  • A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

    Justin Davis;Harris Eyre;Felice N Jacka;Seetal Dodd

  • Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

    Michael Berk;Olivia Dean;Olivia Dean;Olivia Dean;Hemmo Drexhage;John James McNeil

  • C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

    Fernandes Bs;Steiner J;Bernstein Hg;Dodd S;Dodd S

  • Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies.

    David R Skvarc;Michael Berk;Michael Berk;Linda K Byrne;Olivia M Dean

  • Glutathione: a novel treatment target in psychiatry.

    Michael Berk;Michael Berk;Felicity Ng;Olivia Dean;Seetal Dodd

  • Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

    Unknown

  • The glutathione system: a new drug target in neuroimmune disorders.

    Gerwyn Morris;George Anderson;Olivia Dean;Michael Berk;Michael Berk

  • The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial ☆

    Michael Berk;Olivia Dean;Olivia Dean;Olivia Dean;Sue M. Cotton;Clarissa S. Gama

  • The efficacy of adjunctive N-acetylcysteine in major depressive disorder : a double-blind, randomized, placebo-controlled trial

    Michael Berk;Olivia M Dean;Sue M Cotton;Susan Jeavons

  • Minocycline: therapeutic potential in psychiatry.

    Olivia M Dean;João Data-Franco;Francesco Giorlando;Michael Berk

Frequent Co-Authors

Chee H. Ng
Chee H. Ng University of Melbourne
David J. Castle
David J. Castle University of Tasmania
Andrew M. Chanen
Andrew M. Chanen University of Melbourne
Christopher G. Davey
Christopher G. Davey University of Melbourne
Dan I. Lubman
Dan I. Lubman Monash University
Susan L. Rossell
Susan L. Rossell Swinburne University of Technology
Rebecca McKetin
Rebecca McKetin University of New South Wales
Amanda L. Baker
Amanda L. Baker University of Newcastle Australia
Victoria Manning
Victoria Manning Monash University
Simon M Rice
Simon M Rice University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in studying Psychology in the USA, a variety of online degree programs are available to help you start or advance your career. Psychology degrees not only provide a solid foundation in understanding human behavior but also open doors to specialized roles, such as substance abuse counseling and mental health support.

To become a substance abuse counselor, it is crucial to understand the certification requirements, which differ widely depending on the state or city. For example, if you're curious about how to become a substance abuse counselor in Minneapolis, you'll discover specific educational and supervised experience prerequisites. Similarly, the Nashville substance abuse counselor certification requirements and those for New Orleans substance abuse counselor certification requirements highlight the unique accreditation and licensing standards in each area.

For those exploring opportunities in larger metropolitan areas, becoming a substance abuse counselor in New York City requires navigating comprehensive certification pathways. Choosing an online psychology program with a focus on counseling can enhance your knowledge and flexibility, helping you meet local requirements and prepare for a rewarding career.

Best Scientists Citing Olivia M. Dean

Trending Scientists